ΔA146Ply通过调控CYP24A1介导的骨化三醇-维生素D受体通路,诱导铁死亡,从而发挥抗三阴性乳腺癌的作用。
ΔA146Ply exerts anti-triple-negative breast cancer effects by inducing ferroptosis via regulation of the CYP24A1-mediated calcitriol-vitamin D receptor pathway
Ye Yu, Zhengkun Zhang, Dingxue Wang, Xin Bai, Dan He, Xuxu Ji, Zhaoru Yin, Keyi Xu, Ji Liu, Jiaqiong Zou
Journal:TOXICOLOGY AND APPLIED PHARMACOLOGY
IF:3.6
DOI:10.1016/j.taap.2026.118025
PMID:42669384
Published:2026-08-30
research field:肿瘤学分子生物学癌症治疗
Abstract
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype, typically associated with poor clinical outcomes. Recently, ferroptosis has emerged as a promising therapeutic target for TNBC. ΔA146Ply, a novel pneumolysin variant, has demonstrated potential as an anti-tumor agent; however, its role in regulating ferroptosis remains unclear. This study investigates whether ΔA146Ply exerts anti-TNBC effects by promoting ferroptosis via the CYP24A1-mediated Calcitriol/vitamin D receptor (VDR) pathway. Our in vitro results reveal that ΔA146Ply inhibits MDA-MB-231 cells by inducing ferroptosis. Mechanistically, we demonstrate that CYP24A1 negatively regulates the Calcitriol-VDR pathway and serves as a critical mediator of ferroptosis. In vivo , ΔA146Ply suppresses TNBC tumor growth by downregulating CYP24A1 and promoting ferroptosis. In conclusion, ΔA146Ply exerts anti-TNBC effects by activating ferroptosis through the regulation of the CYP24A1-mediated Calcitriol-VDR pathway.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


